P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin's lymphoma

Saved in:
Bibliographic Details
Published in:HemaSphere 2022-10, Vol.6 (Suppl), p.47-47
Main Authors: Mangasarova, Ya.K., Moiseeva, T.N., Al‐Radi, L.S., Margolin, O.V., Gorenkova, L.G., Nesterova, E.S., Bagova, M.O., Fastova, E.A., Abdurashidova, R.R., Sarakaeva, Z.T., Dorokhina, Elena, Kravchenko, S.K., Magomedova, A.U., Zvonkov, E.E.
Format: Article
Language:English
Subjects:
Relapsed/Refractory
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000890972.83229.41